The Administrative/Clinical Trials Core (Core A) is responsible for the administrative support of all DABBreast SPORE Projects, Cores and Programs, including planning and monitoring of scientific activities,providing scientific direction, ensuring a translational research emphasis, and integrating the Projects,Cores and Programs, including collaborations with other Breast SPORES.The Administrative/Clinical TrialsCore provides fiscal oversight including 1) employment of key personnel to ensure cost effective andefficient use of resources and 2) utilization of SPORE flexibility to reallocate funds depending on the degreeto which the individual Projects and Cores of the UAB Breast SPORE are successful in meeting theirperformance benchmarks, which allows the Administrative/Clinical Trials Core to take advantage of newscientific opportunities as well as to remedy deficiencies. The Administrative/Clinical Trials Core provides avital link between investigators and the UAB Breast SPORE internal and external advisors, as well as NCIprogram staff, and assumes responsibility for the preparation of all required reports and assurances.An important component of the Administrative/Clinical Trials Core is its oversight of UAB Breast SPOREhuman clinical trials, which provides for enhanced interactions between the UAB Breast SPORE and theUAB Comprehensive Cancer Center (UABCCC). In regards to the conduct of UAB Breast SPORE humanclinical trials, the goals of the Administrative/Clinical Trials Core are to: 1) provide optimal support forhuman clinical trials; 2) provide patients access to interventions/therapies developed by UAB BreastSPORE investigators; 3) enhance interactions between UAB Breast SPORE basic and clinicalinvestigators; and 4) provide for enhancement and coordination of the resources available through theUABCCC Clinical Trials Shared Facility for utilization by UAB Breast SPORE investigators. Currently, theBreast SPORE has 12 clinical trials generated by SPORE projects, developmental projects or inter-SPOREcollaborations.The Administrative/Clinical Trials Core also manages a registered UAB Breast SPORE website andcontributes to the Cancer Center Magazine, which serves the UAB community and the friends andsupporters of the UABCCC.The Administrative/Clinical Trials Core supports all of the SPORE Projects with planning, monitoring andthe achievement of the scientific objectives of each SPORE Project/Core facility.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA089019-07
Application #
7680151
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
7
Fiscal Year
2008
Total Cost
$281,193
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Wielgos, Monica E; Zhang, Zhuo; Rajbhandari, Rajani et al. (2018) Trastuzumab-Resistant HER2+ Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition. Mol Cancer Ther 17:921-930
Wielgos, Monica E; Rajbhandari, Rajani; Cooper, Tiffiny S et al. (2017) Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast Tumors. Mol Cancer Res 15:340-347
Li, Rong; Zhang, Kui; Penedo, Thuy Linh et al. (2016) The RANK Pathway in Advanced Breast Cancer: Does Src Play a Role? Appl Immunohistochem Mol Morphol 24:42-50
Walters, Beth; Thompson, Sunnie R (2016) Cap-Independent Translational Control of Carcinogenesis. Front Oncol 6:128
Wu, Lizhi; Chaudhary, Sandeep C; Atigadda, Venkatram R et al. (2016) Retinoid X Receptor Agonists Upregulate Genes Responsible for the Biosynthesis of All-Trans-Retinoic Acid in Human Epidermis. PLoS One 11:e0153556
Otali, D; Fredenburgh, J; Oelschlager, D K et al. (2016) A standard tissue as a control for histochemical and immunohistochemical staining. Biotech Histochem 91:309-26
Forero, Andres; Li, Yufeng; Chen, Dongquan et al. (2016) Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells Is Associated with a Good Prognosis and Infiltrating Lymphocytes. Cancer Immunol Res 4:390-9
McNally, Lacey R; Mezera, Megan; Morgan, Desiree E et al. (2016) Current and Emerging Clinical Applications of Multispectral Optoacoustic Tomography (MSOT) in Oncology. Clin Cancer Res 22:3432-9
Atherton, Daniel S; Sexton, Katherine C; Otali, Dennis et al. (2016) Factors Affecting the Use of Human Tissues in Biomedical Research: Implications in the Design and Operation of a Biorepository. Methods Mol Biol 1381:1-38
Hoyt, Kenneth; Umphrey, Heidi; Lockhart, Mark et al. (2015) Ultrasound imaging of breast tumor perfusion and neovascular morphology. Ultrasound Med Biol 41:2292-302

Showing the most recent 10 out of 211 publications